PhotoMedex to Begin Laser Treatment of Psoriasis Clinical Trials
Global skin health solutions company PhotoMedex Inc. announced this month that Dr. John Koo will serve as the principal investigator in a clinical study to assess the efficacy of its Xtrac Velocity excimer laser in the treatment of generalized psoriasis when used in combination with Clobex spray.
Koo’s colleague, Dr. Tina Bhutani will spearhead the study.
When combining the Xtrac Velocity, a laser used to treat psoriasis, with the Clobex spray, a topical agent suitable for use in generalized psoriasis, Bhutani hopes to pioneer an option for treating severe generalized psoriasis with no risk of internal side effects, which are invariably associated with internal agents.
It is anticipated that the combination will reduce the frequency of treatment regimen for psoriasis patients.
In 2008, Koo and his team conducted a successful study with the laser on psoriasis patients who had an affected body surface area (BSA) of 10 to 20 percent. The results of the study helped severe psoriasis sufferers gain access to this technology, said Dennis McGrath, president and CEO of PhotoMedex.
Koo is a professor and vice chairman in the department of dermatology at the University of California San Francisco Medical Center.
For more information, visit:
www.photomedex.com
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024